Shares of Precision Therapeutics Inc (NASDAQ:AIPT) soared Thursday after it announced that its Skyline Medical division significantly expanded its footprint in New England with the sale of six STREAMWAY systems to Yale University’s ambulatory outpatient surgical center.
Skyline's novel FDA-cleared STREAMWAY System suctions surgical waste fluid from the patient using standard surgical tubing and disposables. It connects directly to a hospital’s plumbing system to automate the collection and disposal of waste fluids.
Precision Therapeutics’ stock shot up 10.1% $0.98.
The Eagan, Minnesota, company provides healthcare products and services primarily in the United States. The company manufactures environmentally conscious systems for the collection and disposal of infectious fluids that result from surgical procedures and post-operative care.
The company markets and sells its STREAMWAY Fluid Waste Management system to medical facilities through its sales force and independent distributors.
Contact Uttara Choudhury at [email protected]